Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Diagnosis of Coronary Artery Disease using Myocardial Perfusion SPECT in Patients with Diabetes Mellitus: Analysis of Risk Factors

당뇨병 환자에서 심근관류 SPECT을 이용한 관동맥질환의 진단: 위험인자 분석

  • Seo, Ji-Hyoung (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
  • Kang, Seong-Min (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
  • Bae, Jin-Ho (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
  • Jeong, Shin-Young (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
  • Lee, Sang-Woo (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
  • Yoo, Jeong-Soo (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
  • Ahn, Byeong-Cheol (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
  • Lee, Jae-Tae (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
  • 서지형 (경북대학교 의과대학 핵의학교실) ;
  • 강성민 (경북대학교 의과대학 핵의학교실) ;
  • 배진호 (경북대학교 의과대학 핵의학교실) ;
  • 정신영 (경북대학교 의과대학 핵의학교실) ;
  • 이상우 (경북대학교 의과대학 핵의학교실) ;
  • 유정수 (경북대학교 의과대학 핵의학교실) ;
  • 안병철 (경북대학교 의과대학 핵의학교실) ;
  • 이재태 (경북대학교 의과대학 핵의학교실)
  • Published : 2006.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Diabetes mellitus (DM) is a critical disease with higher rates of cardiovascular morbidity and mortality due to myocardial ischemia and infarction. There is glowing interest in how to determine high-risk patients who are candidates for screening testing. This study was performed to evaluate the incidence of coronary artery disease (CAD) in diabetic patients detected by Tc-99m MIBI myocardial perfusion SPECT (MPS) and to assess risk factors of CAD and cardiac hard events. Subjects and Methods: 203 diabetic patients (64 male, mean age $64.1{\pm}9.0$ years) who underwent MPS were included between Jan 2000 and July 2004. Cardiac death and nonfatal myocardial infarction (MI) were considered as hard events, and coronary angioplasty and bypass surgery >60 days after testing were considered as soft events. The mean follow-up period was $36{\pm}18$ months. Patients underwent exercise (n=6) or adenosine stress (n=197) myocardial perfusion SPECT. Results: Perfusion defects on MPS were detected in 28.6% (58/203) of the patients. There was no cardiac death but 11 hard events were observed. The annual cardiac hard event rate was 1.1%. In univariate analysis of clinical factors, typical anginal pain, peripheral vascular disease, peripheral polyneuropathy, and resting ECG abnormality were significantly associated with the ocurrence of hard events. Anginal pain, peripheral vascular disease, and resting ECG abnormality remained independent predictors of nonfatal MIs with multivariate analysis. Abnormal SPECT results were significantly associated with high prevalence of hard events but not independent predictors on uni- and multivariate analyses. Conclusion: Patients who were male, had longer diabetes duration (especially over 20 years), peripheral vascular disease, peripheral polyneuropathy, or resting ECG abnormality had higher incidence of CAD. Among clinical factors in diabetic patients, typical angina, peripheral vascular disease, peripheral polyneuropathy, and resting ECG abnormality were strong predictors of hard events.

목적 : 당뇨병 환자에서는 관동맥질환의 이환율이 높고 무통성 심근경색과 심근허혈의 빈도가 높아 조기발견이 어렵다. 또한 진단될 당시에 이미 심각한 수준의 관동맥질환을 가지고 있는 경우가 많다. 본 연구에서는 Tc-99m MIBI 심근관류 SPECT을 이용하여 당뇨병 환자에서 관동맥질환의 빈도를 평가하고 전통적인 심장위험 인자들을 포함한 여러 임상시험인자들 중에서 진단이 필요한 고위험군 환자들을 예측할 수 있는 인자들을 알아보고자 하였다. 대상 및 방법 : 2000년 1월부터 2004년 7월 사이에 심근관류 SPECT 검사가 의뢰된 203명의 당뇨병환자(남 64명, 평균연령 $64.9{\pm}9.0$세)를 대상으로 하였다. 심장사망 및 비치명적 심근경색을 중증심장사건으로 정의하였고, 검사 후 60일 이후에 경피적 관동맥성형술이나 관동맥 우회수술을 시행한 정도의 심근허혈의 악화를 경증심장사건으로 정의하였다. 환자들은 운동 부하 (n=6) 혹은 adenosine (n=197) 부하 Tc-99m MIBI 심근관류 SPECT을 시행하였다. 이중검출기(ADAC, USA) 혹은 삼중검출기 감마카메라(PRISM 3000, Picker, USA)를 이용하여 SPECT 영상을 획득하였다. 결과: 심근관류 SPECT 결과 관동맥질환이 진단된 환자들은 58명으로 전체 대상 환자 중 28.6%였다. 총 11건의 중증심장사건, 즉 비치명적 심근경색이 발생하였고 10건의 경증심장사건이 관찰되었다. 전체 대상 당뇨병 환자들의 연간 심장사건 발생률은 1.1%였다. 임상인자들의 단변량 분석 결과, 전형적인 협심증상, 말초혈관병증, 다발성 말초신경병증, 그리고 안정시 심전도상 이상이 심장사건의 발생과 유의한 관련성이 있는 것으로 나타났다. 다변량 분석에서는 전형적인 협심증상, 말초혈관병증, 그리고 안정시 심전도상 이상만이 비치명적 심근경색 발생에 대한 독립적인 예측인자인 것으로 나타났다. SPECT 검사상 관류 이상 소견이 있었던 환자들에게서 중증 심장사건이 일어나는 빈도도 높았으나 심장사건의 독립적인 예측인자는 아니었다. 결론: 당뇨병 환자에서 관동맥질환의 빈도는 정상건강인들에 비해 높았다. 특히 남자, 20년 이상의 긴 당뇨병 이환 기간, 말초혈관병증, 다발성 말초신경병증, 또는 안정시 심전도 이상을 가지고 있는 환자들에서 유의하게 더 높은 빈도로 관동맥질환이 나타남을 알 수 있었다. 그리고 전형적인 협심증상, 말초혈관병증, 다발성 말초신경병증, 안정시 심전도 이상이 있는 환자들에서 이후 중증 심장사건이 발생할 위험이 더 큰 것으로 나타났다.

Keywords

References

  1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34 https://doi.org/10.1056/NEJM199807233390404
  2. Bonow RO, Bohannon N, Hazzard W. Risk stratification in coronary artery disease and special populations. Am J Med 1996; 101:17S-22S https://doi.org/10.1016/S0002-9343(96)00312-9
  3. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 1988;108:1705
  4. Nesto RW. Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care 1999;22:1393-5 https://doi.org/10.2337/diacare.22.9.1393
  5. American Diabetes Association: Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998;21:1551-9 https://doi.org/10.2337/diacare.21.9.1551
  6. Kiat H, Van Train K, Maddahi J, Corbett JR, Nichols K, McGhie AI et al. Development and prospective application of quantitative 2-day stress-rest Tc-99m methoxy isobutyl isonitrile SPECT for the diagnosis of coronary artery disease. Am Heart J 1990;120:1255- 66 https://doi.org/10.1016/0002-8703(90)90234-O
  7. Iskandrian AS, Heo J, Kong B, Lyons E, Marsch S. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. Am J Cardiol 1989;64:270-5 https://doi.org/10.1016/0002-9149(89)90518-3
  8. Maddahi J, Kiat H, Van Train K, Prigent F, Friedman J, Garcia EV et al. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 1990;64:55E-62E
  9. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43 https://doi.org/10.1161/01.CIR.97.6.535
  10. Brown KA. Prognosis in stable coronary artery disease. In: Zaret BL, Beller GA, eds. Nuclear Cardiology: State of the Art and Future Directions. 2nd ed. St Louis, Mo: Mosby Inc; 1999. p.331-45
  11. Berman DS, Hachamovitch R, Kiat H. Cohen I, Cabico JA, Wagn FP et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-47 https://doi.org/10.1016/0735-1097(95)00218-S
  12. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14 https://doi.org/10.1161/01.CIR.93.5.905
  13. Iskandrian AE. Risk assessment of stable patients (Panel II): Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts. J Nucl Cardiol 1999;6:93-155
  14. Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J Am Coll Cardiol 2005;45:50-3 https://doi.org/10.1016/j.jacc.2004.09.055
  15. Miller TD, Rajagopalan N, Hodge DO, Frye RL, Gibbons RJ. Yield of stress single photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J 2004;147:890-6 https://doi.org/10.1016/j.ahj.2003.08.015
  16. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ et al. Detection of ischemia in asymptomatic diabetics: The DIAD study. Diabetes Care 2004;27:1954-61 https://doi.org/10.2337/diacare.27.8.1954
  17. Felsher J, Meissner MD, Hakki AH, Heo J, Kane-Marsch S, Iskandrian AS et al. Exercise thallium imaging in patients with diabetes mellitus. Prognostic implications. Arch Intern Med 1987; 147;313-7 https://doi.org/10.1001/archinte.147.2.313
  18. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;21:535-43
  19. Ladenheim M, Kotler T, Pollach B, Berman DS, Diamond G. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Am J Cardiol 1987;59:270-7 https://doi.org/10.1016/0002-9149(87)90798-3
  20. Hachamovitch R, Berman DS, Cohen I, Cabico A, Friedman JD, Diamond GA et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Circulation 1996; 93:905-14 https://doi.org/10.1161/01.CIR.93.5.905
  21. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40 https://doi.org/10.1161/hc5001.100528
  22. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987;257: 2176-80 https://doi.org/10.1001/jama.257.16.2176
  23. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassman-Vague V et al. Silent myocardial ischemia in patients with diabetes: Who to screen? Diabetes Care 1999;22:1396-400 https://doi.org/10.2337/diacare.22.9.1396
  24. Rutter MK, McComb JM, Brady S, Marshall SM. Silent myocardial ischemia and microalbuminuria in asymptomatic patients with non-insulin dependent diabetes mellitus. Am J Cardiol 1999;83: 27-31 https://doi.org/10.1016/S0002-9149(98)00777-2
  25. Cohen MC, Curran PJ, L'Italien GJ, Mittleman MA, Zarich SW. Long term prognostic value of preoperative dipyridamole thallium imaging and clinical indexes in patients with diabetes mellitus undergoing peripheral vascular surgery. Am J Cardiol 1999;83: 1038-42 https://doi.org/10.1016/S0002-9149(99)00011-9
  26. Milan Study on Atherosclerosis and Diabetes Group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non-insulin dependent diabetes mellitus. Am J Cardiol 1997;79:134-9 https://doi.org/10.1016/S0002-9149(96)00699-6
  27. Zoneraich S, Silverman G, Zoneraich O. Primary myocardial disease, diabetes mellitus, and small vessel disease. Am Heart J 1980;100:754-55 https://doi.org/10.1016/0002-8703(80)90243-4
  28. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991;67:1073-8 https://doi.org/10.1016/0002-9149(91)90868-L